Abiopharma

IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026

Plexus Issues Fiscal 2025 Sustainability Report and Announces Transition to Absolute Emission Reduction Targets

Fate Therapeutics Showcases Clinical Data for FT836 at the American Society of Cancer Oncology Annual Meeting

SOLAI Announces Agreement to Acquire 51% Stake in NEURALAND

Celcuity to Hold Conference Call to Discuss Results for the PIK3CA Mutant Cohort of the Phase 3 VIKTORIA-1 Clinical Trial of Gedatolisib Regimens in HR+/HER- Advanced Breast Cancer on June 2, 2026

Sidus Space Expected Russell Index Inclusion Reflects Continued Execution of Growth and Commercialization Strategy

PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀

Quantum Computing Inc. Announces Attendance at Upcoming Investor Conferences

Fast Track Entertainment Brings Dream Cruises’ 10th Anniversary Celebrity Strategy to Life with Chef Tommie Lee Onboard ‘Genting Dream’

Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH